Us Artificial Intelligence Ai In Medical Imaging Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The U.S. AI in medical imaging market encompasses software and technology solutions that use artificial intelligence to interpret, segment, and analyze clinical images across radiology, cardiology, and pathology. In 2025, the market stands at approximately $0.699 billion, with projections pointing toward $2.93 billion by 2030. No government statistical agency publishes dedicated commercial market figures for this sector, with industry tracking primarily relying on private research estimates.

• •Market valued at approximately $0.699 billion in 2025
• •Projected to reach $2.93 billion by 2030 at a 33.24% CAGR
• •Covers AI applications across CT, MRI, X-ray, ultrasound, and other imaging modalities
• •North America represents the largest regional market globally

The rapid expansion of the market is underpinned by the accelerating pace of FDA clearances for AI-based medical imaging algorithms, particularly in radiology and diagnostic imaging workflows. Rising volumes of medical imaging data, driven by aging populations, increased screening rates, and chronic disease prevalence, create a growing need for AI tools that can help manage workloads and reduce diagnostic turnaround times.

• •FDA has cleared numerous AI medical imaging algorithms, establishing a regulatory pathway for market adoption
• •Growing volume of diagnostic imaging studies strains radiologist capacity, increasing demand for AI-assisted triage
• •Healthcare cost containment pressures motivate adoption of AI tools that can improve efficiency and reduce repeat scans

Within the U.S. market, applications span multiple imaging modalities including radiology, cardiology, neurology, and pathology, with radiology, covering CT, MRI, and X-ray, representing the dominant segment. North America as a whole accounts for a significant share of the global AI medical imaging market, estimated between 37.9% and 45%, reflecting the region's advanced healthcare infrastructure, favorable regulatory environment, and high technology adoption rates.

• •Radiology (X-ray, CT, MRI) constitutes the largest modality segment within the U.S. market
• •North America holds approximately 38% to 45% of the global AI medical imaging market share
• •U.S. market significantly outpaces other North American countries in absolute revenue contribution

What are the recent trends and outlook?

The trajectory of the U.S. market points toward deeper integration of AI into clinical imaging workflows, with a growing emphasis on multimodal AI systems capable of combining data from multiple imaging sources. Value-based care models and the need to improve diagnostic accuracy in underserved or rural communities are expected to further accelerate adoption, while continued FDA clearances will expand the range of FDA-authorized indications for AI imaging tools.

• •Multimodal and generative AI approaches are emerging as next-generation capabilities in imaging analysis
• •Integration with PACS (Picture Archiving and Communication Systems) and EHR platforms is becoming a key differentiator
• •Continued regulatory approvals by the FDA are expected to broaden the scope of reimbursable AI imaging applications